Trials / Completed
CompletedNCT07103577
Guided Island Osteoperiosteal Flap Versus Ridge Splitting for Anterior Atrophic Maxillary
Guided Island Osteoperiosteal Flap Versus Ridge Splitting for Anterior Atrophic Maxillary Augmentation With Implant Placement (a Randomized Controlled Clinical Trial)
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Hams Hamed Abdelrahman · Academic / Other
- Sex
- All
- Age
- 20 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
Background: After tooth extraction changes of the shape of the alveolar bone follows a predictable pattern, which proves to be challenging in restoring its form and function, especially in the esthetic zone. Autogenous grafts remain the gold standard because of their predictability. The island osteoperiosteal flap (I-flap) is introduced as a modified alveolar split bone grafting technique used to gain width, height and modify the facial or buccal bone plate position. Aim of the study: This study aims to evaluate in anterior atrophic maxillary ridge augmentation using guided unreflected island osteoperiosteal flap (I-Flap) approach with simultaneous implant placement and interpostional bone grafting in comparison to computer guided ridge splitting method.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Island osteoperiosteal flap | Crestal incision using no. 15 blade on a bard parker no. 3. Two blind lateral vertical ostotomies at about 1.5 to 2 mm from the adjacent tooth roots to preserve subpapillary and root bone coverage. These cuts are to ensure the complete fracture of buccal plate while being attached to the overlying periosteum. |
| PROCEDURE | Conventional ridge splitting | Crestal incision and 2 vertical releasing incisions will be made using a no.15 blade mounted on a Bard Parker no.3. Then, a full mucoperiosteal flap reflection to expose bone. |
Timeline
- Start date
- 2023-11-05
- Primary completion
- 2025-05-13
- Completion
- 2025-05-13
- First posted
- 2025-08-05
- Last updated
- 2025-08-05
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT07103577. Inclusion in this directory is not an endorsement.